Sarcopenia, Fall and Osteoporosis in Chronic Kidney Disease
1 other identifier
observational
140
1 country
2
Brief Summary
This study is a cross-sectional study that wishes to investigate whether there is an increased incidence of sarcopenia in patients with chronic kidney disease compared to the Danish background population. A possible association between sarcopenia and fall, as well as the incidence of osteoporosis in patients with chronic kidney disease will also be described.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2021
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2020
CompletedFirst Posted
Study publicly available on registry
August 17, 2020
CompletedStudy Start
First participant enrolled
March 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedApril 22, 2024
April 1, 2024
4.8 years
August 13, 2020
April 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in appendicular lean body mass
Difference in appendicular lean body mass between patients with chronic kidney disease and a healthy control group examined in a previous study
Day 0 (day of study procedure)
Secondary Outcomes (8)
Difference in the incidence of sarcopenia
Day 0 (day of study procedure)
Difference in appendicular muscle mass
Day 0 (day of study procedure)
Difference in handgrip strength
Day 0 (day of study procedure)
Difference in gait speed
Day 0 (day of study procedure)
Difference in sit-to-stand test
Day 0 (day of study procedure)
- +3 more secondary outcomes
Study Arms (1)
Participants
This is a cross-sectional study involving approximately 150 patients. They undergo a physical examination, fill out a questionnaire, have blood samples drawn, undergo a Dual Energy X-ray Absorptiometry (DXA) scan and different physical procedures to assess muscle strength and muscle function.
Interventions
Each patient will have their muscle strength and function assessed with the measurements of handgrip strength, 10 m gait speed and a 30 s sit-to-stand test. They will also fill out a questionnaire assessing Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls (SARC-F questionnaire).
Each patient will undergo a physical examination and also deliver blood samples.
Eligibility Criteria
The patients will be recruited from the Department of Nephrology at both Herlev Hospital and Odense University Hospital during their regular visits to these outpatient clinics. All subjects connected to the participating centers are screened to see if they are eligible for the study. Participants with a minimum age of 20 with eGFR ≤30 ml/min are asked if they wish to be examined further to see if they meet all the inclusion criteria and none of the exclusion criteria. Only participants meeting all the inclusion criteria and none of the exclusion criteria will be considered eligible for the trial.
You may qualify if:
- Age ≥20 years
- Chronic kidney disease stage 4-5 not on dialysis (nonD) (corresponding to an estimated glomerular filtration rate (eGFR) ≤30 ml/min based on Kidney Disease Improving Global Outcomes (KDIGO) definition and not on dialysis)
You may not qualify if:
- Kidney transplanted
- Immobilized/hospitalized for more than 1 week within the last 6 weeks
- Active treatment with growth hormone or sex hormone
- Known muscle disease
- The lack of ability to speak or understand Danish
- The lack of ability to give an informed consent
- The lack of ability to participate in a clinical study based on the assessment by the local investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Herlev Hospitallead
- Odense University Hospitalcollaborator
Study Sites (2)
Herlev and Gentofte Hospital, Herlev Hospital
Herlev, 2730, Denmark
Odense University Hospital
Odense, 5000, Denmark
Related Publications (1)
Suetta C, Haddock B, Alcazar J, Noerst T, Hansen OM, Ludvig H, Kamper RS, Schnohr P, Prescott E, Andersen LL, Frandsen U, Aagaard P, Bulow J, Hovind P, Simonsen L. The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20-93 years. J Cachexia Sarcopenia Muscle. 2019 Dec;10(6):1316-1329. doi: 10.1002/jcsm.12477. Epub 2019 Aug 16.
PMID: 31419087BACKGROUND
Biospecimen
Blood samples (serum, plasma)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ditte Hansen, MD, PhD
Department of Nephrology, Herlev and Gentofte Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor, MD, PhD
Study Record Dates
First Submitted
August 13, 2020
First Posted
August 17, 2020
Study Start
March 10, 2021
Primary Completion
January 1, 2026
Study Completion
January 1, 2026
Last Updated
April 22, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
For now no Individual Participant Data (IPD) are planned to be shared with other researchers.